BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 25640353)

  • 21. The epidemiology series of brain-related disorders in Mongolia: nationwide registry-based epidemiological study on CNS tumours in Mongolia, 2015-2019.
    Sandagdorj T; Tudev U; Jamiyandorj O; Oka T; Lkhagvasuren B
    J Integr Neurosci; 2022 Jan; 21(1):24. PubMed ID: 35164460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumors of the central nervous system in Korea: a multicenter study of 3221 cases.
    Suh YL; Koo H; Kim TS; Chi JG; Park SH; Khang SK; Choe G; Lee MC; Hong EK; Sohn YK; Chae YS; Kim DS; Huh GY; Lee SS; Lee YS;
    J Neurooncol; 2002 Feb; 56(3):251-9. PubMed ID: 12061732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: population-based study.
    Stiller CA; Bayne AM; Chakrabarty A; Kenny T; Chumas P
    BMC Cancer; 2019 Feb; 19(1):139. PubMed ID: 30744596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric primary central nervous system tumors registry in Thailand under National Health Security Office schemes.
    Pongtanakul B; Sirachainan N; Surapolchai P; Charoenkwan P; Choeyprasert W; Komwilaisak P; Chainansamit SO; Witsanuyothin N; Lertrakul Y; Rujkijyanont P; Kanjanapongkul S; Sosothikul D; Sanpakit K; Chotsampancharoen T; Wangruangsathit S; Thokanit NS; Tabjareon S; Hongeng S
    J Neurooncol; 2020 Aug; 149(1):141-151. PubMed ID: 32710301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Descriptive epidemiology of germ cell tumors of the central nervous system diagnosed in the United States from 2006 to 2015.
    Gittleman H; Cioffi G; Vecchione-Koval T; Ostrom QT; Kruchko C; Osorio DS; Finlay JL; Barnholtz-Sloan JS
    J Neurooncol; 2019 Jun; 143(2):251-260. PubMed ID: 31025275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Descriptive epidemiology of primary brain and CNS tumors in Delhi, 2003-2007.
    Manoharan N; Julka PK; Rath GK
    Asian Pac J Cancer Prev; 2012; 13(2):637-40. PubMed ID: 22524838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence patterns of central nervous system germ cell tumors: a SEER Study.
    Goodwin TL; Sainani K; Fisher PG
    J Pediatr Hematol Oncol; 2009 Aug; 31(8):541-4. PubMed ID: 19636276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005-2012.
    Lee SH; Jung KW; Ha J; Oh CM; Kim H; Park HJ; Yoo H; Won YJ
    Cancer Res Treat; 2017 Apr; 49(2):494-501. PubMed ID: 27554477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of the Benign Brain Tumor Cancer Registries Amendment Act (Public Law 107-260) on non-malignant brain and central nervous system tumor incidence trends.
    McCarthy BJ; Kruchko C; Dolecek TA
    J Registry Manag; 2013; 40(1):32-5. PubMed ID: 23778695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of central nervous system tumors in Labin area, Croatia, 1974-2001.
    Materljan E; Materljan B; Sepcić J; Tuskan-Mohar L; Zamolo G; Erman-Baldini I
    Croat Med J; 2004 Apr; 45(2):206-12. PubMed ID: 15103760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant central nervous system tumors among adolescents and young adults (15-39 years old) in 14 Southern-Eastern European registries and the US Surveillance, Epidemiology, and End Results program: Mortality and survival patterns.
    Georgakis MK; Papathoma P; Ryzhov A; Zivkovic-Perisic S; Eser S; Taraszkiewicz Ł; Sekerija M; Žagar T; Antunes L; Zborovskaya A; Bastos J; Florea M; Coza D; Demetriou A; Agius D; Strahinja RM; Themistocleous M; Tolia M; Tzanis S; Alexiou GA; Papanikolaou PG; Nomikos P; Kantzanou M; Dessypris N; Pourtsidis A; Petridou ET
    Cancer; 2017 Nov; 123(22):4458-4471. PubMed ID: 28708937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007.
    Baldi I; Gruber A; Alioum A; Berteaud E; Lebailly P; Huchet A; Tourdias T; Kantor G; Maire JP; Vital A; Loiseau H;
    Neuro Oncol; 2011 Dec; 13(12):1370-8. PubMed ID: 21980160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in the incidence of primary brain, central nervous system and intracranial tumors in Israel, 1990-2015.
    Keinan-Boker L; Friedman E; Silverman BG
    Cancer Epidemiol; 2018 Oct; 56():6-13. PubMed ID: 30015055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States.
    Gurney JG; Wall DA; Jukich PJ; Davis FG
    Cancer Causes Control; 1999 Apr; 10(2):101-5. PubMed ID: 10231157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence, time trends and survival patterns of childhood pilocytic astrocytomas in Southern-Eastern Europe and SEER, US.
    Georgakis MK; Karalexi MA; Kalogirou EI; Ryzhov A; Zborovskaya A; Dimitrova N; Eser S; Antunes L; Sekerija M; Zagar T; Bastos J; Agius D; Florea M; Coza D; Bouka E; Bourgioti C; Dana H; Hatzipantelis E; Moschovi M; Papadopoulos S; Sfakianos G; Papakonstantinou E; Polychronopoulou S; Sgouros S; Stefanaki K; Stiakaki E; Strantzia K; Zountsas B; Pourtsidis A; Patsouris E; Petridou ET
    J Neurooncol; 2017 Jan; 131(1):163-175. PubMed ID: 27743145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and survival of children with central nervous system primitive tumors in the French National Registry of Childhood Solid Tumors.
    Desandes E; Guissou S; Chastagner P; Lacour B
    Neuro Oncol; 2014 Jul; 16(7):975-83. PubMed ID: 24470548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimated incidence, prevalence, mortality, and registration of childhood cancer (ages 0-14 years) in the WHO Eastern Mediterranean region: an analysis of GLOBOCAN 2020 data.
    Fadhil I; Soliman R; Jaffar S; Al Madhi S; Saab R; Belgaumi A; Elhaddad A
    Lancet Child Adolesc Health; 2022 Jul; 6(7):466-473. PubMed ID: 35605628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and survival of central nervous system tumors in childhood and adolescence in Girona (Spain) 1990-2013: national and international comparisons.
    Rivas-Vilela S; Rubió-Casadevall J; Fàbrega-Ribas A; Joly-Torta C; Vilardell L; Marcos-Gragera R
    Clin Transl Oncol; 2019 Sep; 21(9):1177-1185. PubMed ID: 30712237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Descriptive epidemiology in population based cancer registries using CNS tumors as an example].
    Stegmaier C; Müller R; Semeniuk E; Ziegler H; Eisinger B; Stabenow R
    Zentralbl Neurochir; 2001; 62(4):137-43. PubMed ID: 12023752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.